Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Prof Andy Black

Andy joined Sygnature Discovery in July 2018 as Non-executive Chairman and has over 20 years of experience in life sciences, including 13 years at CEO and Board level.

Previously, Andy was a Co-Founder and the CEO of Kinapse and developed the business to become a leader in R&D advisory and implementation services to the life sciences industries.  Before this, Andy was a consultant in the health and life sciences sectors for Andersen Consulting/Accenture.

Andy is also Professor of Practice at King’s College London where his activities include research, teaching and administation in support of health schools, businesspartnerships and related topics. Before this, Andy was Head of Strategic Industry Partnerships, responsible for developing large-scale translational researchpartnerships between leading life sciences companies and King’s Health Partners.

Andy trained as a surgeon in the National Health Service after gaining his medical degree (with distinction in surgery) from Guy’s Hospital, London, and he is a Fellow of the Royal College of Surgeons of England.